Personalized medicine involves using a patient's genomic information to better predict disease risk, prognosis, and treatment response. Current genomics-based diagnostic platforms typically use DNA. Dr. Dave Messina is Chief Operations Officer at Cofactor Genomics in St. Louis, MO. He discusses the benefits and the challenges in using RNA sequencing as a diagnostics platform.